Alerts will be sent to your verified email
Verify Email
LALPATHLAB
|
Dr. Lal Pathlabs
|
Metropolis Health.
|
Vijaya Diagnostic
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.49 % | 17.42 % | 19.71 % |
|
5yr Avg Net Profit Margin
|
16.53 % | 13.94 % | 21.45 % |
|
Price to Book
|
12.61 | 8.37 | 13.45 |
|
P/E
|
53.41 | 73.21 | 71.33 |
|
5yr Avg Cash Conversion Cycle
|
-128.38 Days | -103.57 Days | -131.27 Days |
|
5yr Average Interest Coverage Ratio
|
19.96 | 11.6 | 8.11 |
|
5yr Avg ROCE
|
26.99 % | 18.91 % | 21.83 % |
|
5yr Avg Operating Profit Margin
|
26.87 % | 25.91 % | 41.52 % |
|
5 yr average Debt to Equity
|
0.08 | 0.08 | 0.0 |
|
5yr CAGR Net Profit
|
10.81 % | -4.56 % | 11.11 % |
|
5yr Average Return on Assets
|
15.26 % | 10.32 % | 12.95 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
53.79 % | 48.89 % | 52.63 % |
|
Share Pledged by Promoters
|
0.0 | 1.18 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-1.26 % | -0.9 % | -2.41 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
12.21 % | 17.05 % | 10.79 % |
|
Dr. Lal Pathlabs
|
Metropolis Health.
|
Vijaya Diagnostic
|
|---|